Tag: National Institutes of Health
Crisis and Opportunity: Cassava Sciences Still a Strong Buy
“With SAVA, once the pullback has exhausted itself, it’s a strong buy,” we noted on July 29.
Since bottoming out around $65, the stock is...
Why Cassava Sciences Could be a Buy Again on Weakness
On July 22, we mentioned Cassava Sciences was one of the hottest stocks on the market.
In fact, since mentioning it, the stock ran from...